
Merck to Acquire Pandion for ~$1.85B
Shots: Merck to acquire all outstanding share of Pandion for $60/share in cash, representing the equity value of ~$1.85B. The transaction is expected to close […]
Shots: Merck to acquire all outstanding share of Pandion for $60/share in cash, representing the equity value of ~$1.85B. The transaction is expected to close […]
Copyright © 2022 | WordPress Theme by MH Themes